Top Markets
Coin of the day
InhaleRx Limited InhaleRx Limited

InhaleRx Limited

IRX
Rank in Stocks #35421
Established in 2016 and headquartered in Sydney, Australia, InhaleRx Limited is... Established in 2016 and headquartered in Sydney, Australia, InhaleRx Limited is an Australian company primarily engaged in advancing and bringing to market medical drug delivery systems. The firm also dedicates efforts to developing specialized inhaled drug formulations. A notable product within its portfolio is the Medihale inhaler, a distinctive sealed-pod device engineered for compatibility with its inhaled medications. This entity formerly traded as Lifespot Health Ltd, officially adopting the name InhaleRx Limited in October 2021.
Share Price
$0.01657419
Last synced: 2026-03-13
Market Cap
$3.93M
Change (1 day)
0.00%
Change (1 year)
-31.14%
Country
AU
Trade InhaleRx Limited (IRX)

Category

Revenue for InhaleRx Limited (IRX)
Revenue in Aug 2026 TTM: 0
According to InhaleRx Limited latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for InhaleRx Limited from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
$46.59B -
US
$25.84B -
US
$35.48B -
IE
$21.00B -
US
$6.51B -
US